Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Takeda Pharmaceutical patents PKC theta inhibitors

Oct. 14, 2015

Actelion Pharmaceuticals designs CRTH2 antagonists

Oct. 14, 2015

Astellas Pharma describes prostanoid EP4 antagonists

Oct. 14, 2015

Changzhou Jiekai Pharmatech discloses AXL inhibitors

Oct. 13, 2015

Takeda Pharmaceutical develops PKC theta inhibitors

Oct. 13, 2015

Universiteit Antwerpen patents KLK4 inhibitors

Oct. 13, 2015

University of Pennsylvania reports AAVs expressing human OTC

Oct. 13, 2015

Prothena presents anti-LAMA4 MAbs

Oct. 9, 2015

Bayer patents Wnt signaling inhibitors

Oct. 9, 2015

Capella Therapeutics announces EGFR inhibitors

Oct. 9, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...